Trans-cervical double balloon catheter with and without extra-amniotic saline infusion for cervical ripening: a prospective quasi-randomized trial

J Matern Fetal Neonatal Med. 2015 May;28(7):848-53. doi: 10.3109/14767058.2014.935328. Epub 2014 Jul 11.

Abstract

Objective: To compare the efficacy and safety of the trans-cervical double balloon catheter with and without extra-amniotic saline infusion (EASI) for cervical ripening.

Methods: This is a secondary analysis of a prospective randomized study conducted between November 2007 and January 2011 evaluating different ripening methods. Women presenting for labor induction were assigned to receive the double balloon catheter with (study group) or without EASI (control group). Outcomes included time from device insertion to delivery, cesarean section rates, and adverse events.

Results: One hundred and sixty women completed the study. Cesarean section rate (8.3% in study group, versus 20% in controls p = 0.07) and ripening success were comparable between the groups. Catheter insertion to delivery interval was significantly shorter and spontaneous catheter expulsion rate was significantly higher in the study group (14:19 hours versus 20:45 hours, p < 0.001, and 68.5% versus 51%, p = 0.04, respectively). Hospitalization length was significantly shorter in the study arm. There were no differences in other outcomes evaluated. A multivariable analysis found the EASI to be an independent predictor of a shorter insertion to delivery interval.

Conclusions: The addition of EASI to the double balloon catheter for cervical ripening results in a shorter labor induction process without compromising its safety.

Trial registration: ClinicalTrials.gov NCT00604487.

Keywords: Atad catheter; cesarean section rate; induction to delivery interval; labor induction; mechanical ripening.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Catheterization / adverse effects
  • Catheterization / instrumentation
  • Catheterization / methods*
  • Cervical Ripening*
  • Cesarean Section / statistics & numerical data
  • Female
  • Humans
  • Infusions, Parenteral
  • Labor, Induced / adverse effects
  • Labor, Induced / methods*
  • Length of Stay / statistics & numerical data
  • Outcome Assessment, Health Care
  • Pregnancy
  • Prospective Studies
  • Sodium Chloride / administration & dosage*
  • Time Factors

Substances

  • Sodium Chloride

Associated data

  • ClinicalTrials.gov/NCT00604487